Katholieke Universiteit Leuven KU Leuven Research & Development;University Hospital Antwerp
发明人:
申请号：
EP18152406.7
公开号：
EP3329909A1
申请日:
2014.05.01
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Fenfluramine or its pharmaceutically acceptable salt for use in a method of treating and / or preventing Dravet Syndrome in a patient, such as a patient previously diagnosed with Dravet Syndrome, wherein the method comprises administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient.
